Sattar Rabia, Ali S Abid, Abbasi Atiya
HEJ Research Institute of Chemistry, International Centre for Chemical Sciences, University of Karachi, Pakistan.
Biochem Biophys Res Commun. 2003 Aug 29;308(3):497-504. doi: 10.1016/s0006-291x(03)01394-9.
Caspases, the intracellular cysteine proteinases, play a central role in the process of programmed cell death. Caspases induce apoptosis through a highly integrated and regulated biological, biochemical, and genetic mechanism. Although proper execution of apoptosis is fundamental for cell growth artificial caspase inhibition can be considered in certain degenerative diseases. This realization has attracted attention towards caspases as likely targets for pharmaceutical intervention. Here we analyze the structure of caspase-6 and also predict the possible glycosylation, phosphorylation, and myristoylation sites as very little is known about the functional role of these post translational modifications in the caspase family. These studies are expected to improve our understanding of associations of caspases with other molecules and the possible role played in apoptosis. The predicted tertiary structure of caspase-6 as well as the enzyme complexed with its inhibitor (tetra-peptide aldehyde Ac-IETD-CHO) shows similar binding feature as seen in other caspases. Cys/His catalytic dyad for caspase-6 and -8 show possible involvement of a third component, i.e., Pro29 and Arg258 in caspase-6 and caspase-8, respectively. Changes in the length and nature of loop between alpha5 and beta9, involved in defining the S4 subsite, result in modification of P4 (Ile) site. These interactions provide detail of inhibitor binding on structural level and also help in designing mutants for structure-function studies of these enzymes.
半胱天冬酶作为细胞内的半胱氨酸蛋白酶,在程序性细胞死亡过程中发挥着核心作用。半胱天冬酶通过高度整合且受调控的生物学、生物化学及遗传学机制诱导细胞凋亡。尽管细胞凋亡的正常执行对于细胞生长至关重要,但在某些退行性疾病中可以考虑人为抑制半胱天冬酶。这一认识已引起人们将半胱天冬酶视为药物干预潜在靶点的关注。在此,我们分析了半胱天冬酶-6的结构,并预测了可能的糖基化、磷酸化和豆蔻酰化位点,因为对于这些翻译后修饰在半胱天冬酶家族中的功能作用知之甚少。这些研究有望增进我们对半胱天冬酶与其他分子关联以及在细胞凋亡中可能发挥作用的理解。预测的半胱天冬酶-6三级结构以及与其抑制剂(四肽醛Ac-IETD-CHO)复合的酶显示出与其他半胱天冬酶类似的结合特征。半胱天冬酶-6和-8的半胱氨酸/组氨酸催化二元组分别显示出第三个组分(即半胱天冬酶-6中的Pro29和半胱天冬酶-8中的Arg258)可能参与其中。参与定义S4亚位点的α5和β9之间环的长度和性质变化导致P4(异亮氨酸)位点的改变。这些相互作用在结构层面提供了抑制剂结合的细节,也有助于设计用于这些酶结构-功能研究的突变体。